<DOC>
	<DOCNO>NCT00425165</DOCNO>
	<brief_summary>The purpose trial evaluate effect single dose denufosol versus placebo mucociliary clearance patient mild moderate CF lung disease</brief_summary>
	<brief_title>Study Denufosol Inhalation Solution Patients With Mild Moderate Cystic Fibrosis Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>confirm diagnosis cystic fibrosis FEV1 great equal 60 % predict normal age , gender , height able reproducibly perform spirometry maneuver clinically stable least 4 week prior screen abnormal renal liver function chest xray screen abnormality suggest clinically significant active pulmonary disease lung transplant</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>